HOMOLOGY MEDICINES Trademark

Trademark Overview

On Friday, February 9, 2018, a trademark application was filed for HOMOLOGY MEDICINES with the United States Patent and Trademark Office. The USPTO has given the HOMOLOGY MEDICINES trademark a serial number of 87791657. The federal status of this trademark filing is REGISTERED as of Tuesday, November 12, 2019. This trademark is owned by Homology Medicines, Inc.. The HOMOLOGY MEDICINES trademark is filed in the Pharmaceutical Products category with the following description:

House mark for pharmaceuticals
homology medicines

General Information

Serial Number87791657
Word MarkHOMOLOGY MEDICINES
Filing DateFriday, February 9, 2018
Status700 - REGISTERED
Status DateTuesday, November 12, 2019
Registration Number5910664
Registration DateTuesday, November 12, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Disclaimer with Predetermined Text"MEDICINES"
Goods and ServicesHouse mark for pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 16, 2018
Primary Code005
First Use Anywhere DateThursday, July 18, 2019
First Use In Commerce DateThursday, July 18, 2019

Trademark Owner History

Party NameHomology Medicines, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBedford, MA 01730
Party NameHomology Medicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBedford, MA 01730

Trademark Events

Event DateEvent Description
Tuesday, November 12, 2019REGISTERED-SUPPLEMENTAL REGISTER
Monday, October 7, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 30, 2019ASSIGNED TO LIE
Wednesday, September 25, 2019NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, September 24, 2019APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Tuesday, September 24, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, September 24, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 24, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, September 24, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 24, 2019NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Saturday, September 21, 2019EXAMINER'S AMENDMENT ENTERED
Saturday, September 21, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, September 21, 2019EXAMINERS AMENDMENT E-MAILED
Saturday, September 21, 2019EXAMINERS AMENDMENT -WRITTEN
Saturday, September 21, 2019USE AMENDMENT ACCEPTED
Wednesday, August 7, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 6, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 6, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, August 6, 2019AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, August 6, 2019USE AMENDMENT FILED
Monday, August 5, 2019TEAS AMENDMENT OF USE RECEIVED
Wednesday, February 6, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 6, 2019FINAL REFUSAL E-MAILED
Wednesday, February 6, 2019FINAL REFUSAL WRITTEN
Monday, December 10, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, December 10, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, December 1, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 30, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 30, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, June 3, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, June 3, 2018NON-FINAL ACTION E-MAILED
Sunday, June 3, 2018NON-FINAL ACTION WRITTEN
Thursday, May 24, 2018ASSIGNED TO EXAMINER
Friday, February 16, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 13, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

medicines homology pharmaceuticals mark house